The inside of the Athenry facility. [Image from Dexcom on LinkedIn]Dexcom (Nasdaq:DXCM) said today that it has officially opened its manufacturing and office development in Athenry, Ireland. The San Diego-based continuous glucose monitor (CGM) maker broke ground on the facility in January 2024. It said in 2023 that it expected to invest $325 million in Athenry. Last month, an Irish construction company said it completed work on the facility, put…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.